Modulation of Butyrate Anticancer Activity by Solid Lipid Nanoparticle Delivery: An in Vitro Investigation on Human Breast Cancer and Leukemia Cell Lines
Purpose. Histone modification has emerged as a promising approach to cancer therapy. The short-chain fatty acid, butyric acid, a histone deacetylase (HD) inhibitor, has shown anticancer activity. Butyrate transcriptional activation is indeed able to withdraw cancer cells from the cell cycle, leading...
Saved in:
Main Authors: | Federica Foglietta (Author), Loredana Serpe (Author), Roberto Canaparo (Author), Nicoletta Vivenza (Author), Giovanna Riccio (Author), Erica Imbalzano (Author), Paolo Gasco (Author), Gian Paolo Zara (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ultrasound Triggers Hypericin Activation Leading to Multifaceted Anticancer Activity
by: Federica Foglietta, et al.
Published: (2022) -
Exploiting Lipid and Polymer Nanocarriers to Improve the Anticancer Sonodynamic Activity of Chlorophyll
by: Federica Bosca, et al.
Published: (2020) -
Anticancer effects of sodium butyrate on human colon cancer Caco2 cell line
by: Flora Forouzesh, et al.
Published: (2018) -
5-Aminolevulinic Acid Triggered by Ultrasound Halts Tumor Proliferation in a Syngeneic Model of Breast Cancer
by: Federica Foglietta, et al.
Published: (2021) -
Development of ARPE-19-Equipped Ocular Cell Model for In Vitro Investigation on Ophthalmic Formulations
by: Simona Sapino, et al.
Published: (2023)